


Jalosome®
Jalosome® JalosomeJalosome® is the first and only product specially developed against dermatitis related to radio- and chemotherapy. Its local anti-inflammatory and pain reducing properties have also been studied in other skin inflammations such as GvHD. QUALITATIVE...
GHN Pharma Metabolic AB and Pharmaelle Srl, today announced a strategic agreement to launch Aldixyl® in Denmark, Finland, Island, Norway and Sweden.
GHN Pharma Metabolic AB and Pharmaelle Srl, today announced a strategic agreement to launch Aldixyl® in Denmark, Finland, Island, Norway and Sweden. GHN Pharma Metabolic AB is a local company focusing on products within rare metabolic diseases. GHN Pharma Metabolic is...
GHN Pharma Nordic – Rejselegat
GHN Pharma Nordic – Rejselegat I forbindelse med DHS 50 års jubilæum uddeler GHN Pharma Nordic et rejselegat. Legatet er tiltænkt som økonomisk støtte til læger, der er ansat ved en af landets Hæmatologiske afdelinger og som ønsker et bidrag til...
Sweden’s Covid strategy a failure, Corona virus commission tell us.
Sweden’s Covid strategy a failure, Corona virus commission tell us. Sweden failed to protect care home residents from the coronavirus and the government is to blame – although other individual agencies and authorities bear responsibility – according to the...